Article Details

Gilead Stock – Europe stocks up on Gilead's remdesivir as COVID-19 infections spike

Retrieved on: 2021-04-07 03:56:15

Tags for this article:

Click the tags to see associated articles and topics

Gilead Stock – Europe stocks up on Gilead's remdesivir as COVID-19 infections spike. View article details on hiswai:

Excerpt

O said on Thursday it had agreed to sell Europe up to 500,000 courses of its antiviral drug remdesivir, as the continent shores up supplies of one of ...

Article found on: fintechzoom.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up